Angiogenic protein expression in advanced epithelial ovarian cancer

Clinical Cancer Research

Volumn 3, Issue 9, 1997, Pages 1579-1586

  Barton, Desmond P J ^a   Cai, Ann ^b   Wendt, Karl ^c   Young, Martin ^a   Gamero, Anna ^d   De Cesare, Steve ^d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b TEMPLE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 8; CD34 ANTIGEN; VASCULOTROPIN;

ADULT; ADVANCED CANCER; ANGIOGENESIS; ARTICLE; ASCITES FLUID; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ANTIGENS, CD34; ASCITIC FLUID; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROTEINS; RIBONUCLEASE, PANCREATIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030838780     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
3. Folkman, J., and Hanahan, D. Switch to the angiogenic phenotype during tumorigenesis. In: C. C. Harris (ed.), Multistage Carcinogenesis, pp. 339-347. Tokyo: APAN Sci. Soc. Press, and Boca Raton, FL: CRC Press, 1992.
4. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
5. Smith-McCune, K. K., and Weidner, N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res., 54: 800-804, 1994.
6. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor in microvascular endothelial cells. Biochem. Biophys. Res. Commun., 181: 902-906, 1991.
7. Polverini, P. J., and Leibovich, S. J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab. Invest., 51: 635-642, 1984.
8. Leek, R. D., Harris, A. L., and Lewis, C. E. Cytokine networks in solid human tumors: regulation of angiogenesis. J. Leuk. Biol., 56: 423-435, 1994.
9. Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66: 1095-1104, 1991.
10. Christofori, G., and Hanahan, D. Molecular dissection of multistage tumorigenesis in transgenic mice. Semin. Cancer Biol., 5: 3-12, 1994.
11. Brem, H., and Klagsbrun, M. The role of fibroblast growth factors and related oncogenes in tumor growth. In: C. C. Benz and E. T. Liu (eds), Oncogenes and Tumor Suppressor Genes in Human Malignancies, pp. 211-231. Boston: Kluwer Academic Publishers, 1993.
12. Wright, J. A., Turley, E. A., and Greenberg, A. H. Transforming growth factor ß and fibroblast growth factor as promotors of tumor progression to malignancy. Crit. Rev. Oncog., 4: 473-492, 1993.
13. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Lemuel Bethune, J., Riordan, J. F., and Vallee, B. L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24: 5480-5486, 1985.
14. Rybak, S. M., Fett, J. W., Yao, Q-Z., and Vallee, B. L. Angiogenin mRNA in human tumor and normal cells. Biochem. Biophys. Res. Commun., 146: 1240-1248, 1987.
15. Shapiro, R., Strydom, D. J., Olson, K. A., and Vallee, B. L. Isolation of angiogenin from normal human plasma. Biochemistry, 26: 5141-5146, 1987.
16. Soncin. F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl. Acad. Sci. USA, 89: 2232-2236, 1992.
17. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. J. Biol. Chem., 226: 11947-11954, 1991.
18. Ferrara, N., Houch, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
19. Plate, K. H., Brier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
20. Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van De Water, L., and Senger, D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med., 174: 1275-1278, 1991.
21. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
22. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
23. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
24. Barton, D. P. J., Blanchard, D. K., Wells, A. F., Nicosia, S. V., Roberts, W. S., Cavanagh, D., and Djeu, J. Y. Expression of interleukin-2 receptor α mRNA and protein in advanced epithelial ovarian cancer. Anticancer Res., 15: 716-722, 1994.
25. Klagsbrun, M., and D'Amore, P. A. Regulators of angiogenesis. Ann. Rev. Physiol., 53: 217-239, 1991.
26. Zaloudek, C. The ovary. In: C. Compel and S. G. Silverberg (eds.), Pathology in Obstetrics and Gynaecology, Ed. 4, pp. 313-412. Philadelphia: J. B. Lippincott, 1994.
27. Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenbert, M. L., and Merino, M. J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol., 147: 33-41, 1995.
28. Shimoyama, S., Gansauge, F., Gansauge, S., Negri, G., Oohara, T., and Beger, H. G. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res., 56: 2703-2706, 1996.
29. Fujimoto, K., Ichimori, Y., Kakizoe, T., Okajima, E., Sakamoto, H., Sugimura, T., and Terada, M. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys Res. Commun., 180: 386-392, 1991.
30. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., and Folkman, J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241-242, 1993.
31. Li, V. W., Folkerth, R. D., Watanabe, H., Yu, C., Rupnick, M., Barnes, P., Scott, R. M., M. Black, P., Sallan, S. E., and Folkman, J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet, 344: 82-86, 1994.
32. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
33. Yeo, K-T., Wang, H. H., Nagy, J. A., Sioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, F., M., Senger, D. R., Dvorak, H. F., and Yeo, T-K. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res., 53: 2912-2918, 1993.
34. Sheid, B. Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer. Cancer Lett., 62: 153-158, 1992.
35. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamuar, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.
36. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S., and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor. Cancer Res., 56: 2185-2190, 1996.
37. Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54: 276-280, 1994.
38. Fava, R. A., Olsen, N. J., Spencer-Green, G., Yeo, K-T., Yeo, T-K., Berse, B., Jackman, R. W., Senger, D. R., Dvorak, H. F., and Brown, L. F. Vascular permeability factor/endothelial growth factor (VPF/ VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346, 1994.
39. Ferrara, N., Winer, J., Burton, T., Rowland, A., Seigel, M., Phillips, H. S., Terrell, T., Keller, G. A., and Levinson, A. D. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. Clin. Invest., 91: 160-170, 1993.
40. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189: 824-832, 1992.
41. Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation, 92 (Suppl. II): 365-371, 1995.
42. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
43. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
44. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
45. Boocock, C. A., Charnock-Jones, D. S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A., Twentyman, P. R., and Smith, S. K. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J. Natl. Cancer Inst., 87: 506-516, 1995.
46. Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res., 56: 2671-2676, 1996.
47. Gasparini, G., Weidner, N., Bevilacqua, P., Maluta, S., Palma, P. D., Caffo, O., Barbareschi, M., Boracchi, P., Marubini, E., and Pozza, F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol., 12: 454-466, 1994.
48. Weidner, N., Caroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.